17,261 trials
Neoplasms, Breast
Primary: Number of Participants With Overall Response (OR), Defined as Those Participants Achieving Complete Response (CR) or Partial Response (PR), Assessed Per Response…
Bipolar Depression
Primary: The 25-Item Hamilton Depression Rating Scale. — 23.3; 22.1; 17.5; 18.5 units on a scale
Metastatic Breast Cancer
Primary: Percentage of Participants With Objective Response (OR; Assessed by Response Evaluation Criteria in Solid Tumors [RECIST] Version 1.1) — 60.0; 52.0 percentage of…
Carcinoma, Hepatocellular
Primary: Tumour Stabilisation Rate — 5.3; 16.0; 8.7 percentage of patients
Carcinoma, Transitional Cell · Bladder Cancer · Bladder Neoplasm
Primary: Objective Response Rate (ORR) — 1 participants
Intraventricular Hemorrhage
Primary: 30-day Mortality — 1; 1; 6 Number of participants
Adenocarcinoma of the Prostate · Stage I Prostate Cancer · Stage II Prostate Cancer
Primary: Concentration of Lycopene in Prostatic Surgical Tissue — 0.663; 0.378; 0.723; 0.165 ug/dL
Lung Cancer · Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung
Primary: Immune-related Progression-free Survival (irPFS) in Participants With Nonsmall-cell Lung Cancer (NSCLC) Per Immune-related Response Criteria (irRC) — 5.52; 5.68; 4.63…
Gastrointestinal Stromal Tumors · Soft Tissue Sarcomas
Primary: Change in Standardised Uptake Value (SUV)Max at Day 8, Central Review, (GIST) Gastrointestinal Stromal Tumours Patients. — -0.515 g/mL
AML · Acute Myeloid Leukemia · Myelodysplastic Disorders
Primary: Maximum Tolerated Dose (MTD) — 400 milligrams/twice a day (BID)
Influenza
Primary: Seroprotection Pre- and Post- Vaccination — 18.5; 12.5; 19.1; 15.4 % of Participants
Neurofibromatosis 1 · Neurofibroma, Plexiform
Primary: Median Time to Disease Progression — 13.2 Months
Major Depression
Primary: Montgomery Asberg Depression Rating Scale (MADRS) — 22.629; 26.102; 29.455 Score on a scale — p=.018
Prostate Cancer
Primary: Number of Patients With a PSA Response — 4; 27 participants
Renal Cell Cancer · Stage IV Renal Cell Cancer
Primary: Objective Response Rate Assessed by RECIST Criteria. — 0; 3; 5; 9 participants